News and Publications

Improved Pharma presenting at AAPS 2020 PHARMSCI 360 with Rapid Fire Presentation and Poster

WEST LAFAYETTE, IND. (PRWEB) OCTOBER 26, 2020 Interact with us via poster number 924440 and the Advances and Innovation in Formulation Development Rapid Fire session. On Wednesday October 28th, Dr. Pamela Smith, COO of Improved Pharma, will present “Synchrotron-Based Formulation Development” in the Rapid Fire: Formulation and Quality – Chemical session. Those registered for the meeting Read more

Improved Pharma presenting at AAPS 2020 PHARMSCI 360 with Rapid Fire Presentation and Poster2020-10-26T17:34:00+00:00

Published book chapter on Solid-State Characterization

Improved Pharma COO Pamela Smith is co-author of a chapter in the latest edition of Specification of Drug Substances and Products: Development and Validation of Analytical Methods. The chapter, Solid-State Characterization – Method Development and Validation, focuses on the key issues that must be addressed when developing solid-state methods. Method development and validation for pharmaceuticals is Read more

Published book chapter on Solid-State Characterization2020-10-21T15:04:46+00:00

Excipient Effects on Drug Product Performance

Traditionally, excipients utilized for the development of pharmaceutically-marketed drug products have been considered largely inert. Excipients are added to formulations for a variety of reasons that may include assisting processability of the drug product formulation, controlling the disintegration rate to facilitate regional dissolution along the gastrointestinal tract (GIT), bulking up the dosage form to enable Read more

Excipient Effects on Drug Product Performance2020-09-21T19:19:30+00:00

Improved Pharma Announces New UV-Vis Capabilities and Expanded Dissolution Services

WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 15, 2020 Improved Pharma has expanded their offerings by acquiring S. I. Photonics’ top-of-the-line spectrophotometer, model 440. This model has a high sensitivity, low noise CCD detector that enables the collection of a full spectrum within a second. The power of this instrument is enhanced by the number of accessories and Read more

Improved Pharma Announces New UV-Vis Capabilities and Expanded Dissolution Services2020-09-16T19:51:23+00:00

Improved Pharma Announces New Collaborations Enabling Expansion Of Services

WEST LAFAYETTE, IND. (PRWEB) JULY 20, 2020 Improved Pharma is pleased to announce new collaborations with Westport Pharmaceutical Consulting, LLC (dba WPC, LLC) and Ravine Pharmaceuticals LLC enabling expansion of expertise and service offerings to the pharmaceutical industry in support of drug substance and drug product development. These additions bring a vast amount of relevant industrial Read more

Improved Pharma Announces New Collaborations Enabling Expansion Of Services2020-07-21T14:03:08+00:00

Learn about Improved Pharma’s approach to polymorph and salt screening

Polymorph screens and salt screens are important components for drug development. The goal of polymorph screening is to try to find all possible crystal forms by small-scale crystallization and to select a stable form that can be manufactured and formulated into a dosage form. Salt screens are commonly used to alter the physicochemical properties of Read more

Learn about Improved Pharma’s approach to polymorph and salt screening2020-07-15T20:52:18+00:00

Improved Pharma Introduces Synchrotron-Based Fast to IND (S-fIND) Development Services

Accelerated development is a complex and difficult task. S-fIND (Synchrotron-based fast to IND) is a strategy to speed development of the most difficult cases using powerful X-ray methods only available at a Synchrotron X-ray source.  S-fIND integrates powerful methods with practical pharmaceutical development approaches and excellent people in a package that accelerates development. Accelerated development services Read more

Improved Pharma Introduces Synchrotron-Based Fast to IND (S-fIND) Development Services2020-06-04T00:32:02+00:00

Improved Pharma Announces New Raman Microscopy Abilities and Collaboration with Chemical Microscopy, LLC

WEST LAFAYETTE, IND. (PRWEB) JUNE 02, 2020 In response to growing demands for services, Improved Pharma, LLC is pleased to announce a collaboration with Dr. Dale K. Purcell of Chemical Microscopy, LLC to provide services related to microscopy and microspectroscopy to Improved Pharma clients. With this collaboration comes the acquisition of HORIBA’s Xplora Series Raman Microscope. Raman mapping is a powerful Read more

Improved Pharma Announces New Raman Microscopy Abilities and Collaboration with Chemical Microscopy, LLC2020-06-02T21:38:49+00:00

Are Polymorphs Obvious?

Not according to the United States Court of Appeals, citing Improved Pharma’s CSO Steve Byrn’s early paper on polymorph screening. The United States Court of Appeals for the Federal Circuit is known as the Supreme Court of patents, and its rulings are typically considered as significant landmarks in the patent and innovation field.  In a Read more

Are Polymorphs Obvious?2020-06-01T17:24:49+00:00

Improved Pharma announces expansion of services to include infrared microspectroscopy and hot stage optical microscopy

WEST LAFAYETTE, IN (PRWEB) MAY 06, 2020 Improved Pharma has added new capabilities to their existing microscopy services. Now in addition to stereomicroscopy and polarized light microscopy, Improved Pharma can provide analysis via infrared microspectroscopy and hot stage optical microscopy. Improved Pharma has expanded their in-house microscopy services. In addition to stereomicroscopy and polarized light Read more

Improved Pharma announces expansion of services to include infrared microspectroscopy and hot stage optical microscopy2020-05-06T12:50:10+00:00